Engineered phage with cell-penetrating peptides for intracellular bacterial infections

ABSTRACT Salmonella infection poses a critical challenge to global public health, and the situation is exacerbated by the increasing prevalence of antibiotic resistance. Bacteriophages (phages) are increasingly being used as antimicrobial agents due to their ability to kill specific bacteria. Howeve...

Full description

Bibliographic Details
Main Authors: Min Zhao, Xin Tan, Zi-qiang Liu, Lei Dou, Dong Liu, Yong-jun Pan, Ying-fei Ma, Jia-lin Yu
Format: Article
Language:English
Published: American Society for Microbiology 2023-10-01
Series:mSystems
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/msystems.00646-23
_version_ 1797617671652507648
author Min Zhao
Xin Tan
Zi-qiang Liu
Lei Dou
Dong Liu
Yong-jun Pan
Ying-fei Ma
Jia-lin Yu
author_facet Min Zhao
Xin Tan
Zi-qiang Liu
Lei Dou
Dong Liu
Yong-jun Pan
Ying-fei Ma
Jia-lin Yu
author_sort Min Zhao
collection DOAJ
description ABSTRACT Salmonella infection poses a critical challenge to global public health, and the situation is exacerbated by the increasing prevalence of antibiotic resistance. Bacteriophages (phages) are increasingly being used as antimicrobial agents due to their ability to kill specific bacteria. However, the low cellular uptake of phages has limited their use in treating intracellular bacterial infections. Here, we present a study using engineered phages with cell-penetrating peptides (CPPs) for enhancing the internalization efficiency of phages to inhibit bacterial intracellular infections. Through bioinformatic analysis, we identified a phage-encoded protein harboring an immunoglobulin-like (Ig-like) domain as the potential target for phage display. Using a CRISPR-Cas9-based method, we successfully displayed short peptides on GP94, an Ig-like domain-containing protein, of Salmonella phage selz. We improved phage intracellular uptake in multiple cell types by fusion of various CPPs to GP94. Notably, the phage selzHA-TAT showed promising results in enhancing the intracellular inhibition of Salmonella in different cells. Our research provides a straightforward strategy for displaying CPPs on non-model phages, offering a promising novel and effective therapeutic approach for treating intracellular and drug-resistant bacteria. IMPORTANCE Salmonella infection is a significant threat to global public health, and the increasing prevalence of antibiotic resistance exacerbates the situation. Therefore, finding new and effective ways to combat this pathogen is essential. Phages are natural predators of bacteria and can be used as an alternative to antibiotics to kill specific bacteria, including drug-resistant strains. One significant limitation of using phages as antimicrobial agents is their low cellular uptake, which limits their effectiveness against intracellular bacterial infections. Therefore, finding ways to enhance phage uptake is crucial. Our study provides a straightforward strategy for displaying cell-penetrating peptides on non-model phages, offering a promising novel and effective therapeutic approach for treating intracellular and drug-resistant bacteria. This approach has the potential to address the global challenge of antibiotic resistance and improve public health outcomes.
first_indexed 2024-03-11T07:59:06Z
format Article
id doaj.art-c1667747fad84243a7d2666e8ab9af8e
institution Directory Open Access Journal
issn 2379-5077
language English
last_indexed 2024-03-11T07:59:06Z
publishDate 2023-10-01
publisher American Society for Microbiology
record_format Article
series mSystems
spelling doaj.art-c1667747fad84243a7d2666e8ab9af8e2023-11-17T03:22:37ZengAmerican Society for MicrobiologymSystems2379-50772023-10-018510.1128/msystems.00646-23Engineered phage with cell-penetrating peptides for intracellular bacterial infectionsMin Zhao0Xin Tan1Zi-qiang Liu2Lei Dou3Dong Liu4Yong-jun Pan5Ying-fei Ma6Jia-lin Yu7Department of Neonatology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing Key Laboratory of Pediatrics , Chongqing, ChinaCAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences , Shenzhen, ChinaCAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences , Shenzhen, ChinaDepartment of Neonatology, Southern University of Science and Technology Hospital , Shenzhen, ChinaDepartment of Neonatology, Shenzhen People’s Hospital , Shenzhen, ChinaDepartment of Critical Care Medicine, Southern University of Science and Technology Hospital , Shenzhen, ChinaCAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences , Shenzhen, ChinaDepartment of Neonatology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing Key Laboratory of Pediatrics , Chongqing, ChinaABSTRACT Salmonella infection poses a critical challenge to global public health, and the situation is exacerbated by the increasing prevalence of antibiotic resistance. Bacteriophages (phages) are increasingly being used as antimicrobial agents due to their ability to kill specific bacteria. However, the low cellular uptake of phages has limited their use in treating intracellular bacterial infections. Here, we present a study using engineered phages with cell-penetrating peptides (CPPs) for enhancing the internalization efficiency of phages to inhibit bacterial intracellular infections. Through bioinformatic analysis, we identified a phage-encoded protein harboring an immunoglobulin-like (Ig-like) domain as the potential target for phage display. Using a CRISPR-Cas9-based method, we successfully displayed short peptides on GP94, an Ig-like domain-containing protein, of Salmonella phage selz. We improved phage intracellular uptake in multiple cell types by fusion of various CPPs to GP94. Notably, the phage selzHA-TAT showed promising results in enhancing the intracellular inhibition of Salmonella in different cells. Our research provides a straightforward strategy for displaying CPPs on non-model phages, offering a promising novel and effective therapeutic approach for treating intracellular and drug-resistant bacteria. IMPORTANCE Salmonella infection is a significant threat to global public health, and the increasing prevalence of antibiotic resistance exacerbates the situation. Therefore, finding new and effective ways to combat this pathogen is essential. Phages are natural predators of bacteria and can be used as an alternative to antibiotics to kill specific bacteria, including drug-resistant strains. One significant limitation of using phages as antimicrobial agents is their low cellular uptake, which limits their effectiveness against intracellular bacterial infections. Therefore, finding ways to enhance phage uptake is crucial. Our study provides a straightforward strategy for displaying cell-penetrating peptides on non-model phages, offering a promising novel and effective therapeutic approach for treating intracellular and drug-resistant bacteria. This approach has the potential to address the global challenge of antibiotic resistance and improve public health outcomes.https://journals.asm.org/doi/10.1128/msystems.00646-23phage engineeringcell-penetrating peptidephage therapyintracellular infection
spellingShingle Min Zhao
Xin Tan
Zi-qiang Liu
Lei Dou
Dong Liu
Yong-jun Pan
Ying-fei Ma
Jia-lin Yu
Engineered phage with cell-penetrating peptides for intracellular bacterial infections
mSystems
phage engineering
cell-penetrating peptide
phage therapy
intracellular infection
title Engineered phage with cell-penetrating peptides for intracellular bacterial infections
title_full Engineered phage with cell-penetrating peptides for intracellular bacterial infections
title_fullStr Engineered phage with cell-penetrating peptides for intracellular bacterial infections
title_full_unstemmed Engineered phage with cell-penetrating peptides for intracellular bacterial infections
title_short Engineered phage with cell-penetrating peptides for intracellular bacterial infections
title_sort engineered phage with cell penetrating peptides for intracellular bacterial infections
topic phage engineering
cell-penetrating peptide
phage therapy
intracellular infection
url https://journals.asm.org/doi/10.1128/msystems.00646-23
work_keys_str_mv AT minzhao engineeredphagewithcellpenetratingpeptidesforintracellularbacterialinfections
AT xintan engineeredphagewithcellpenetratingpeptidesforintracellularbacterialinfections
AT ziqiangliu engineeredphagewithcellpenetratingpeptidesforintracellularbacterialinfections
AT leidou engineeredphagewithcellpenetratingpeptidesforintracellularbacterialinfections
AT dongliu engineeredphagewithcellpenetratingpeptidesforintracellularbacterialinfections
AT yongjunpan engineeredphagewithcellpenetratingpeptidesforintracellularbacterialinfections
AT yingfeima engineeredphagewithcellpenetratingpeptidesforintracellularbacterialinfections
AT jialinyu engineeredphagewithcellpenetratingpeptidesforintracellularbacterialinfections